In brief, the variation of the ApoB/ApoA1 ratio arising from the progress of CHB disease is worth studying, and it can indirectly suggest the effect exerted by the progress of CHB disease on atherosclerosis, and add novel insights for the early diagnosis of LC and HCC. This evidence concerns the gene APOB and hepatocellular carcinoma.